MUNICH
Germany
21
2022-09-22
The entities that hold a legal rights for patent applications filed by inventor HINNER MARLON:
MARLON HINNER from MUNICH, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
ENGINEERED T CELLS AND USES THEREFOR
#2 | 2022-05-12Proteins specific for CD137
#3 | 2021-12-30Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)
#4 | 2021-11-25NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1
#5 | 2021-07-01ANTI-CANCER FUSION POLYPEPTIDE
#6 | 2020-12-03Specific-binding polypeptides and uses thereof
#7 | 2020-05-14NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF
#8 | 2019-11-07Proteins specific for calcitonin gene-related peptide
#9 | 2019-10-10Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)
#10 | 2019-01-10Anti-cancer fusion polypeptide
#11 | 2018-05-31Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides
#12 | 2018-05-31Proteins specific for CD137
#13 | 2018-05-24Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
#14 | 2018-01-25Engineered T cells and uses therefor
#15 | 2017-06-22NOVEL BINDING PROTEINS FOR PCSK9
#16 | 2017-06-15Proteins specific for calcitonin gene-related peptide
#17 | 2017-04-20Specific-binding polypeptides and uses thereof
#18 | 2016-01-28Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9
#19 | 2015-12-03Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
#20 | 2015-01-01Methods and compositions for treating disorders
#21 | 2014-09-25Human tear lipocalins which bind PCSK9 and methods of use thereof
913138 ⎘